Novonesis A/S Stock

Equities

NSIS B

DK0060336014

Specialty Chemicals

Real-time Estimate Cboe Europe 06:21:40 2024-04-25 am EDT 5-day change 1st Jan Change
389 DKK +0.30% Intraday chart for Novonesis A/S +1.52% +4.69%
Sales 2024 * 29.41B 4.23B Sales 2025 * 31.35B 4.51B Capitalization 180B 25.92B
Net income 2024 * 3.86B 555M Net income 2025 * 5.1B 734M EV / Sales 2024 * 6.61 x
Net Debt 2024 * 14.23B 2.05B Net Debt 2025 * 12.52B 1.8B EV / Sales 2025 * 6.15 x
P/E ratio 2024 *
44 x
P/E ratio 2025 *
33.8 x
Employees 6,577
Yield 2024 *
1.47%
Yield 2025 *
1.73%
Free-Float 75.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.19%
1 week+1.52%
Current month-4.12%
1 month-4.29%
3 months+6.18%
6 months+39.85%
Current year+4.69%
More quotes
1 week
378.10
Extreme 378.1
393.80
1 month
375.90
Extreme 375.9
411.80
Current year
343.90
Extreme 343.9
421.70
1 year
274.60
Extreme 274.6
421.70
3 years
274.60
Extreme 274.6
545.80
5 years
254.10
Extreme 254.1
545.80
10 years
220.70
Extreme 220.7
545.80
More quotes
Date Price Change Volume
24-04-25 388.5 +0.15% 63 836
24-04-24 387.9 -0.15% 661,333
24-04-23 388.5 +0.91% 596,603
24-04-22 385 -0.52% 384,864
24-04-19 387 +1.12% 356,165

Delayed Quote Nasdaq Copenhagen, April 25, 2024 at 06:05 am EDT

More quotes
Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
387.9 DKK
Average target price
430.9 DKK
Spread / Average Target
+11.08%
Consensus
  1. Stock Market
  2. Equities
  3. NSIS B Stock